A 19-year-old woman presented to her general practitioner with a purpuric rash 3 weeks after receiving her first 150 mg intramuscular injection of depot medroxyprogesterone acetate (DMPA) at a family planning clinic. She had no medical or family history of note and was taking no other medication. Following investigation by the haematology department she was diagnosed with thrombocytopenic purpu...

Depo-medroxyprogesterone acetate (DMPA) is an increasingly popular contraceptive choice among Navajo women. Weight gain is cited as a common side effect and major reason for discontinuation of DMPA. No controlled trials have evaluated the association between weight gain and DMPA in Navajo women. We aimed to clarify whether DMPA is associated with weight gain in Navajo women and to quantify the ...

Introduction: Pregnancies can be either planned or unplanned. Unplanned pregnancies are a major public health issue globally causing poor maternal and foetal outcomes. Addressing this problem would improve the well-being of antenatal mothers their children. Family planning is an important step to minimise burden unplanned pregnancies. Objective: To determine prevalence family preferences in Thi...

BACKGROUND Our objective was to conduct a pilot study to determine if transcervical administration of polidocanol foam (PF) with or without doxycycline or benzalkonium chloride (BZK) would prevent pregnancy in baboons. METHODS In study phase 1, adult cycling baboons underwent a hysterosalpingogram to evaluate tubal patency prior to transcervical infusion of 20 mL of 5% PF followed by 1 mL of ...

BACKGROUND This study evaluated the effect of immediate postpartum depot medroxyprogesterone (DMPA) on breastfeeding cessation within 6 weeks postpartum. STUDY DESIGN At low-income-serving obstetric and pediatric clinics, eligible mothers within 1 year postpartum were recruited to participate in a retrospective cohort study. The 183 participants completed a self-administered survey. Surveys w...

OBJECTIVE To investigate the impact of a long-acting injectable progestin, depo-medroxyprogesterone acetate (DMPA), compared with combination oral contraceptives (COCs) on the risk of diabetes in Latino women with prior gestational diabetes mellitus (GDM). RESEARCH DESIGN AND METHODS An observational cohort study of 526 Hispanic women with prior GDM who were not diabetic in their postpartum v...

bjective: To determine the effect of duration using Depo Medroxyprogesterone Acetate (DMPA) on Menstrual Cycle.Methods: This research is an analytical study 102 patients who used DMPA for less than 1 year and more then analyzed types menstrual disorders experienced while contraception at RSIA Masyita Makassar Tahun 2022. Data collection was carried out by direct observation RSIA. arranged in a ...

A new class of antiandrogen medications, gonadotropin-releasing hormone agonists, offers promise in the treatment of the paraphilias, with substantially less side effects than medroxyprogesterone acetate or cyproterone acetate. This paper reports the results of treatment using a depot suspension of leuprolide acetate on 12 patients with paraphilic disorders or with sexual disorders not otherwis...